Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts

PURPOSE: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin (Cb) to anthracycline/taxane chemotherapy improves pathological complete response (pCR) in triple negative breast cancer (TNBC). Effectiveness of anthracycline-free, platinum combinations in TNBC is not well known. Her...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Cancer Res
Hauptverfasser: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, Jose Angel, Ward, Claire, Connor, Carol S., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Augusti, Picornell, Antoni C., del Monte-Millán, Maria, Gonzalez-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortes, Javier, Fuentes, Hugo, Bretel, Denisse, Márquez-Rodas, Iván, Perou, Charles M., Wagner, Jamie L., Mammen, Joshua V., McGinness, Marilee K., Klemp, Jennifer R., Amin, Amanda L., Fabian, Carol J., Heldstab, Jaimie, Godwin, Andrew K., Jensen, Roy A., Kimler, Bruce F., Khan, Qamar J., Martin, Miguel
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156592/
https://ncbi.nlm.nih.gov/pubmed/27301700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0162
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge